Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
$4,889,710N01FY2024AINIH
Anivive Lifesciences, Inc, Long Beach CA
Investigators
Abstract
To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.
View original record on NIH RePORTER →